To meet the ever-growing regulatory demands of evidence generation while addressing need for efficiency, pharmaceutical and biotech organizations must break down functional silos for strategic alignment, streamline process improvement, and leverage new tools and technologies along the way. Jon this pioneering panel to learn how to tackle these challenges strategically and practically:  

• Addressing the perennial productivity challenges in the pharmaceutical and biotech industry
• Breaking down functional silos to meet the rigorous demands for evidence generation and process optimization
• Creating a culture of continuous improvement that aligns with broader business objectives
• Developing an integrated change plan and change leadership to drive and sustain transformational initiatives

As more and more companies embark on their agile transformation journey, it is important to have a clear understanding on the ROI. Can agile really improve productivity, decrease risks and costs and increase revenue? This panel will share key experiences and insights:

·       Why are some agile programs not delivering the expected ROI? Understanding the key factors of success for agile transformation

·       What strategic outcomes do we need to achieve, including objectives and key results (OKRs)?

·       Beyond driving for outcomes, what other company initiatives do we need to deliver to move the business forward?

·       How do we know we’ve achieved our goals? What are the key metrics to determine the ROI of agile transformation?